These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1759173)

  • 1. Allogeneic bone marrow transplantation for severe aplastic anemia.
    Speck B
    Semin Hematol; 1991 Oct; 28(4):319-21. PubMed ID: 1759173
    [No Abstract]   [Full Text] [Related]  

  • 2. Allogeneic hematopoietic stem cell transplantation for childhood aplastic anemia: prospective trial in China.
    Chun C; Fang JP; Xue HM; Zhou DH; Huang K; Xu HG; Huang SL
    Transfus Apher Sci; 2011 Feb; 44(1):41-7. PubMed ID: 21256085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow transplantation for severe aplastic anemia. Effect of a preparative regimen of cyclophosphamide-low-dose total-lymphoid irradiation and posttransplant cyclosporine-methotrexate therapy.
    Champlin RE; Ho WG; Nimer SD; Gajewski JG; Selch M; Burnison M; Holley G; Yam P; Petz L; Winston DJ
    Transplantation; 1990 Apr; 49(4):720-4. PubMed ID: 2326866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hematopoietic stem-cell transplantation in aplastic anemia].
    Hernández-Rivera EG
    Rev Invest Clin; 2005; 57(2):298-304. PubMed ID: 16524071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tacrolimus/Methotrexate versus cyclosporine/methotrexate as graft-versus-host disease prophylaxis in patients with severe aplastic anemia who received bone marrow transplantation from unrelated donors: results of matched pair analysis.
    Yagasaki H; Kojima S; Yabe H; Kato K; Kigasawa H; Sakamaki H; Tsuchida M; Kato S; Kawase T; Muramatsu H; Morishima Y; Kodera Y
    Biol Blood Marrow Transplant; 2009 Dec; 15(12):1603-8. PubMed ID: 19896085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow transplantation for severe aplastic anemia: influence of conditioning and graft-versus-host disease prophylaxis regimens on outcome.
    Gluckman E; Horowitz MM; Champlin RE; Hows JM; Bacigalupo A; Biggs JC; Camitta BM; Gale RP; Gordon-Smith EC; Marmont AM
    Blood; 1992 Jan; 79(1):269-75. PubMed ID: 1728315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone marrow transplantation for pediatric patients with severe aplastic anemia in Taiwan.
    Lin KH; Chen RL; Lin DT; Lui LT; Lin KS
    Transplant Proc; 1993 Aug; 25(4 Suppl 3):61-4. PubMed ID: 8351722
    [No Abstract]   [Full Text] [Related]  

  • 8. [Allogeneic bone marrow transplantation for aplastic anemia].
    Ohashi H
    Nihon Rinsho; 1990 Sep; 48(9):2096-101. PubMed ID: 2232216
    [No Abstract]   [Full Text] [Related]  

  • 9. A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantation.
    Winston DJ; Antin JH; Wolff SN; Bierer BE; Small T; Miller KB; Linker C; Kaizer H; Lazarus HM; Petersen FB; Cowan MJ; Ho WG; Wingard JR; Schiller GJ; Territo MC; Jiao J; Petrarca MA; Tonetta SA
    Bone Marrow Transplant; 2001 Jul; 28(2):187-96. PubMed ID: 11509937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Marrow transplantation in aplastic anemia.
    Storb R; Buckner CD; Fefer A; Clift RA; Neiman PE; Gluksberg H; Lerner KG; Thomas ED
    Transplant Proc; 1974 Dec; 6(4):355-8. PubMed ID: 4612891
    [No Abstract]   [Full Text] [Related]  

  • 11. [The use of allogeneic bone marrow transplantation and immunosuppressive therapy in the treatment of patients with acquired aplastic anemia].
    Ganapiev AA; Golubovskaia IK; Zalialov IuR; Estrina MA; Afanas'ev BV
    Ter Arkh; 2010; 82(7):48-52. PubMed ID: 20853609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective trial of mycophenolate mofetil-cyclosporine A prophylaxis for acute GVHD after G-CSF stimulated allogeneic bone marrow transplantation with HLA-identical sibling donors in patients with severe aplastic anemia and hematological malignancies.
    Ostronoff F; Ostronoff M; Souto-Maior AP; Domingues M; Sucupira A; Manso DA; de Lima AK; Monteiro PG; Florêncio R; Calixto R
    Clin Transplant; 2009; 23(1):33-8. PubMed ID: 18727660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current results of bone marrow transplantation in patients with acquired severe aplastic anemia. Report of the European Group for Blood and Marrow transplantation. On behalf of the Working Party on Severe Aplastic Anemia of the European Group for Blood and Marrow Transplantation.
    Bacigalupo A; Oneto R; Bruno B; Socié G; Passweg J; Locasciulli A; Van Lint MT; Tichelli A; McCann S; Marsh J; Ljungman P; Hows J; Marin P; Schrezenmeier H
    Acta Haematol; 2000; 103(1):19-25. PubMed ID: 10705155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for acute graft-versus-host disease in 325 consecutive bone marrow recipients.
    Hägglund H; Boström L; Ringdén O; Nilsson B; Remberger M
    Transplant Proc; 1994 Jun; 26(3):1821-2. PubMed ID: 8030154
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term follow-up of a randomized trial of graft-versus-host disease prevention by methotrexate/cyclosporine versus methotrexate alone in patients given marrow grafts for severe aplastic anemia.
    Storb R; Leisenring W; Deeg HJ; Anasetti C; Appelbaum F; Bensinger W; Buckner CD; Clift R; Doney K; Hansen J
    Blood; 1994 May; 83(9):2749-50. PubMed ID: 8167353
    [No Abstract]   [Full Text] [Related]  

  • 16. HLA-DP matching in allogeneic bone marrow transplantation.
    Pawelec G; Ehninger G; Schmidt H; Rehbein A; Balko I; Wernet P
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2741-3. PubMed ID: 3274584
    [No Abstract]   [Full Text] [Related]  

  • 17. A retrospective analysis of long-term survival in severe aplastic anemia patients treated with allogeneic bone marrow transplantation or immunosuppressive therapy with antithymocyte globulin and cyclosporin A at a single institution.
    Ellis RJ; Kahn Q; Skikne BS; Mayo MS; Allgood JW; Bodensteiner DM; Deauna-Limayo D; Cook JD
    Mil Med; 2002 Jul; 167(7):541-5. PubMed ID: 12125844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term follow-up of allogeneic stem cell transplantation in patients with severe aplastic anemia after conditioning with cyclophosphamide plus antithymocyte globulin.
    Kröger N; Zabelina T; Renges H; Krüger W; Kordes U; Rischewski J; Schrum J; Horstmann M; Ayuk F; Erttmann R; Kabisch H; Zander AR
    Ann Hematol; 2002 Nov; 81(11):627-31. PubMed ID: 12454700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One-hundred-ten patients with aplastic anemia (AA) treated by marrow transplantation in Seattle.
    Storb R; Thomas ED; Weiden PL; Buckner CD; Clift RA; Fefer A; Goodell BW; Johnson FL; Neiman PE; Sanders JE; Singer J
    Transplant Proc; 1978 Mar; 10(1):135-40. PubMed ID: 24905
    [No Abstract]   [Full Text] [Related]  

  • 20. Bone marrow transplantation (BMT) for acquired severe aplastic anaemia (SAA): long term follow-up of 107 consecutive patients.
    Socie G; Gluckman E; Devergie A; Girinsky T; Esperou H; Cosset JM
    Bone Marrow Transplant; 1991; 7 Suppl 2():102. PubMed ID: 1878665
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.